Conference announcement｜EASL Congress(2023)

doi:10.3969/j.issn.1001-5256.2023.05.gnwhydd1

Volume 39 Issue 5

May 2023

Turn off MathJax

Article Contents

References

Article Navigation > Journal of Clinical Hepatology > 2023 > 39(5): 1133-1133

PDF( 854 KB)

Conference announcement｜EASL Congress(2023)

DOI: 10.3969/j.issn.1001-5256.2023.05.gnwhydd1

Published Date: 2023-05-20

Abstract

FullText(HTML)

References(0)

References

Relative Articles

[1]	Danqin SUN, Jiaqi SHEN, Minghua ZHENG. An excerpt of an international Delphi consensus statement on metabolic dysfunction-associated fatty liver disease and risk of chronic kidney disease （2023）[J]. Journal of Clinical Hepatology, 2024, 40(1): 42-45. doi: 10.12449/JCH240108
[2]	Haofeng XIONG, Liying. SUN. An excerpt of American Association for the Study of Liver Diseases practice guidance on acute-on-chronic liver failure and the management of critically ill patients with cirrhosis in 2023[J]. Journal of Clinical Hepatology, 2024, 40(4): 679-681. doi: 10.12449/JCH240406
[3]	Yi BAI, Jinming LI, Yamin ZHANG. An excerpt of European Society for Organ Transplantation consensus statement on biomarkers in liver transplantation （2023）[J]. Journal of Clinical Hepatology, 2024, 40(2): 252-257. doi: 10.12449/JCH240206
[4]	Bohan LUO, Guohong HAN. An excerpt of AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis （2023）[J]. Journal of Clinical Hepatology, 2024, 40(1): 33-36. doi: 10.12449/JCH240106
[5]	Junyuan ZHU, Xiao LIU, Yawei CHENG, Qingchen WANG, Xiaochen LIU, Yuhua ZHU, Chunqing ZHANG. An excerpt of Asia-Pacific Association for the Study of the Liver guidelines on management of ascites in liver disease （2023）[J]. Journal of Clinical Hepatology, 2024, 40(1): 37-41. doi: 10.12449/JCH240107
[6]	Annual Meeting of the European Association for the Study of the Liver （EASL 2024）[J]. Journal of Clinical Hepatology, 2024, 40(4): 725-725.
[7]	Henglu BIAN, Jiasu LI, Cui LIU, Feng LIU. An excerpt of AASLD practice guidance on the use of TIPS， variceal embolization， and retrograde transvenous obliteration in the management of variceal hemorrhage in 2023[J]. Journal of Clinical Hepatology, 2023, 39(11): 2564-2568. doi: 10.3969/j.issn.1001-5256.2023.11.008
[8]	Xiaodong ZHOU, Na TIAN, Minghua ZHENG. Excerpt of an international multidisciplinary consensus statement on MAFLD and the risk of CVD （2023）[J]. Journal of Clinical Hepatology, 2023, 39(10): 2336-2339. doi: 10.3969/j.issn.1001-5256.2023.10.010
[9]	Jidong JIA, Junqi NIU. Fly in the Wind, Take a Lead—Speech of the Editors-in-Chief of Journal of Clinical Hepatology in 2023[J]. Journal of Clinical Hepatology, 2023, 39(1): 9-9.
[10]	Huiying RAO. Key points in hepatitis C guidance 2023 update： American Association for the Study of Liver Diseases-Infectious Diseases Society of America recommendations for testing， managing， and treating hepatitis C virus infection[J]. Journal of Clinical Hepatology, 2023, 39(12): 2798-2803. doi: 10.3969/j.issn.1001-5256.2023.12.008
[11]	Zheran CHEN, Lei XIN, Luowei WANG. Key points in pancreatic cancer： ESMO clinical practice guideline for diagnosis， treatment and follow-up （2023）[J]. Journal of Clinical Hepatology, 2023, 39(12): 2804-2808. doi: 10.3969/j.issn.1001-5256.2023.12.009
[12]	Wenjing NI, Jie LI, Jiangao FAN. A brief introduction of AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease in 2023[J]. Journal of Clinical Hepatology, 2023, 39(5): 1049-1055. doi: 10.3969/j.issn.1001-5256.2023.05.008
[13]	Kechun WANG, Mingda WANG, Tian YANG. Key points in AASLD Practice Guidance on Prevention， Diagnosis， and Treatment of Hepatocellular Carcinoma （2023）[J]. Journal of Clinical Hepatology, 2023, 39(9): 2081-2086. doi: 10.3969/j.issn.1001-5256.2023.09.008
[14]	Manman XU, Nan GENG, Yu CHEN. An excerpt of EASL clinical practice guidelines on acute－on－chronic liver failure （2023）[J]. Journal of Clinical Hepatology, 2023, 39(10): 2321-2327. doi: 10.3969/j.issn.1001-5256.2023.10.008
[15]	Huimin LIU, Wenting CHEN, Shilian LI, Hongmei GONG, Qing. MAO. Key points of EASL Clinical Practice Guidelines on hepatitis delta virus （2023）[J]. Journal of Clinical Hepatology, 2023, 39(11): 2558-2563. doi: 10.3969/j.issn.1001-5256.2023.11.007
[16]	Guanlun ZHOU, Yuhao JU, Jing XU, Ping ZHANG, Guorong HAN. An excerpt of EASL clinical practice guidelines on the management of liver diseases in pregnancy （2023）[J]. Journal of Clinical Hepatology, 2023, 39(10): 2328-2335. doi: 10.3969/j.issn.1001-5256.2023.10.009
[17]	AASLD Congress (2023)[J]. Journal of Clinical Hepatology, 2023, 39(9): 2184-2184. doi: 10.3969/j.issn.1001-5256.2023.09.gnwhydd1
[18]	APASL STC 2022:Liver fibrosis in the era of translational medicine[J]. Journal of Clinical Hepatology, 2022, 38(4): 836-836. doi: 10.3969/j.issn.1001-5256.2022.04.gnwhydd1
[19]	Dai MingJia, Yan XueBing. A comparative analysis of 2014 and 2015 EASL guidelines for anti-HCV therapy[J]. Journal of Clinical Hepatology, 2015, 31(10): 1595-1598. doi: 10.3969/j.issn.1001-5256.2015.10.008
[20]	Duan WeiJiaYi, Jia JiDong. The European Society of Hepatology (EASL)2010 Guidelines for the Clinical Diagnosis and Treatment of HFE Gene-Related Hematochromia [J]. Journal of Clinical Hepatology, 2010, 26(4): 348-348.